How Providence is integrating precision medicine at scale

This webinar is on-demand and can be viewed at your convenience.

Most health systems still treat genomic testing as a downstream step — ordered late, received late and rarely integrated into the broader care plan. Providence is doing it differently.

By embedding genomics directly into clinical workflows, including pathology-initiated testing that delivers meaningful insights at the point of diagnosis, Providence Genomics has built a model that connects testing, care delivery, and research at scale.

This session features Carlo Bifulco, MD, Chief Medical Officer of Providence Genomics, who walks through how the organization moved from fragmented, reactive care to a proactive, data-driven approach across oncology, prevention, pharmacogenomics and population health.

Key takeaways:

How pathology-initiated testing ensures clinicians have genomic insights at the point of diagnosis
Why precision medicine programs are expanding beyond oncology into prevention and pharmacogenomics
How integrating genomics with EHRs, AI tools, and care teams enables systemwide scalability
How genomic data access supports clinical trial enrollment and continuous innovation

Presenters:

Carlo Bifulco, MD